Contact : +61 413 227 332

All posts by LiVac Team

Mergermarket interviews Livac CEO, Dr Anabela Correia

Livac is actively seeking AUD $6m to support US market entry

Article by Louise Weihart – mergermarket, Sept 2019

Livac, a privately held Melbourne-based Australian developer of devices to support minimally invasive surgery (MIS), is actively seeking AUD 6m (USD 4m) from new investors to support US market entry, said CEO Anabela Correira.

Read More

LiVac achieves key milestone in US marketing entry strategy

Livac Pty Ltd, an Australian medical device company, after having completed all necessary regulatory requirements of the US Food and Drug Administration, can now proceed with supply of their organ retraction system “the LiVac™ Retractor System” in the US market.

Read More

Livac Shareholder Update

First use in robotic bariatric procedure

The first use of the LiVac™ Retractor in a robotic bariatric procedure was recently conducted in Melbourne. The LiVac™ Retractor was used for the first time with a da Vinci® robot and retracted the liver throughout the duration of the Laparoscopic Sleeve Gastrectomy case. The surgeon involved went on to apply for the LiVac™ to be listed and commercially available at his hospital.

Read More

Livac in The Edge, Malaysia

The Surgeon Turned Inventor – Article by Tan Zhai Yun, April 2019

Dr Philip Gan, a Malaysian-born surgeon based in Australia, is on a mission to make surgery less painful and invasive. Over the years, he has observed how certain procedures and traumatic for patients and wanted to do something to change this.

Read More